News & Analysis as of

Supreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications for Nanotech

Today the Supreme Court rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA segments are patent eligible based on the patent eligibility...more

Myriad’s Impact on Nanotechnology? Nanotechnology’s Impact on Myriad??

On April 15, 2013, the Supreme Court will hear oral arguments in the Myriad Genetics v. Association for Molecular Pathology litigation. The patent world is watching, particularly those who focus on emerging technologies. On...more

2 Results
|
View per page
Page: of 1